Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 8Breast Neoplasms 6Prostatic Neoplasms 4Lung Neoplasms 4Stomach Neoplasms 3Agnosia 3Pain 2Neoplasms 2Meningioma 2Colorectal Neoplasms 2Supratentorial Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Pain, Intractable 1Oropharyngeal Neoplasms 1Neuroblastoma 1Neoplasm Metastasis 1Liver Neoplasms 1Liver Diseases 1Kidney Neoplasms 1Ganglion Cysts 1Esophageal Neoplasms 1Emergence Delirium 1ENT Cancers 1Cystic Adenomatoid Malformation of Lung, Congenital 1Colonic Neoplasms 1Carpal Tunnel Syndrome 1Cancer Pain 1Bronchopulmonary Sequestration 1

Interventions

Saline Solution 2Mannitol 2Ropivacaine 1Propofol 1Long-Term Synaptic Depression 1HES 130-0.4 1Dexmedetomidine 1Desflurane 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Supratentorial Neoplasms × Ropivacaine × Clear all
NCT06157359 2024-08-09

Effect of SNB on the QoR in Patients Undergoing Supratentorial Tumor Resection

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Unknown
84 enrolled

Supratentorial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡